Bowling Portfolio Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.52M | Sell |
57,472
-3,217
| -5% | -$156K | 0.69% | 36 |
|
|
2022
Q2 | $3.18M | Sell |
60,689
-67
| -0.1% | -$3.41K | 0.8% | 28 |
|
|
2022
Q1 | $3.15M | Sell |
60,756
-741
| -1% | -$38.4K | 0.68% | 34 |
|
|
2021
Q4 | $3.63M | Sell |
61,497
-270
| -0.4% | -$13.4K | 0.75% | 25 |
|
|
2021
Q3 | $2.66M | Buy |
61,767
+684
| +1% | +$30.3K | 0.6% | 34 |
|
|
2021
Q2 | $2.39M | Buy |
61,083
+31,256
| +105% | +$1.22M | 0.53% | 48 |
|
|
2021
Q1 | $1.08M | Sell |
29,827
-21,671
| -42% | -$769K | 0.26% | 134 |
|
|
2020
Q4 | $1.9M | Sell |
51,498
-6,202
| -11% | -$227K | 0.45% | 58 |
|
|
2020
Q3 | $2.01M | Buy |
57,700
+24,100
| +72% | +$845K | 0.45% | 43 |
|
|
2020
Q2 | $1.04M | Sell |
33,600
-222
| -0.7% | -$7.54K | 0.22% | 112 |
|
|
2020
Q1 | $1.05M | Sell |
33,822
-4,124
| -11% | -$141K | 0.26% | 107 |
|
|
2019
Q4 | $1.41M | Sell |
37,946
-620
| -2% | -$22.1K | 0.24% | 119 |
|
|
2019
Q3 | $1.31M | Sell |
38,566
-1,441
| -4% | -$52.4K | 0.22% | 161 |
|
|
2019
Q2 | $1.64M | Sell |
40,007
-20,993
| -34% | -$834K | 0.27% | 126 |
|
|
2019
Q1 | $2.46M | Sell |
61,000
-441
| -0.7% | -$17.7K | 0.39% | 76 |
|
|
2018
Q4 | $2.54M | Sell |
61,441
-138,557
| -69% | -$5.75M | 0.45% | 66 |
|
|
2018
Q3 | $8.36M | Sell |
199,998
-8,105
| -4% | -$312K | 1.17% | 8 |
|
|
2018
Q2 | $7.16M | Sell |
208,103
-6,322
| -3% | -$216K | 1% | 13 |
|
|
2018
Q1 | $7.22M | Sell |
214,425
-1,893
| -0.9% | -$65.1K | 0.99% | 10 |
|
|
2017
Q4 | $7.43M | Buy |
216,318
+165,773
| +328% | +$5.65M | 0.99% | 10 |
|
|
2017
Q3 | $1.71M | Sell |
50,545
-465
| -0.9% | -$14.9K | 0.26% | 119 |
|
|
2017
Q2 | $1.63M | Buy |
51,010
+97
| +0.2% | +$3.06K | 0.24% | 118 |
|
|
2017
Q1 | $1.65M | Sell |
50,913
-248,975
| -83% | -$7.85M | 0.27% | 112 |
|
|
2016
Q4 | $9.24M | Sell |
299,888
-51,285
| -15% | -$1.57M | 1.37% | 5 |
|
|
2016
Q3 | $11.3M | Buy |
351,173
+234,782
| +202% | +$7.85M | 1.58% | 3 |
|
|
2016
Q2 | $3.89M | Sell |
116,391
-122,841
| -51% | -$3.92M | 0.64% | 69 |
|
|
2016
Q1 | $6.73M | Buy |
239,232
+138,582
| +138% | +$3.96M | 1.09% | 28 |
|
|
2015
Q4 | $3.08M | Buy |
100,650
+5,173
| +5% | +$163K | 0.68% | 61 |
|
|
2015
Q3 | $2.85M | Buy |
95,477
+1,663
| +2% | +$53.3K | 0.66% | 66 |
|
|
2015
Q2 | $2.98M | Sell |
93,814
-48,516
| -34% | -$1.58M | 0.65% | 61 |
|
|
2015
Q1 | $4.7M | Sell |
142,330
-1,144
| -0.8% | -$36.4K | 1.03% | 34 |
|
|
2014
Q4 | $4.24K | Buy |
143,474
+33,256
| +30% | +$954K | 0.86% | 37 |
|
|
2014
Q3 | $3.09M | Buy |
110,218
+1,124
| +1% | +$31.5K | 0.73% | 63 |
|
|
2014
Q2 | $3.07M | Buy |
109,094
+1,432
| +1% | +$40.8K | 0.73% | 66 |
|
|
2014
Q1 | $3.28M | Sell |
107,662
-1,877
| -2% | -$56K | 0.78% | 61 |
|
|
2013
Q4 | $3.18M | Buy |
109,539
+280
| +0.3% | +$8.15K | 0.78% | 60 |
|
|
2013
Q3 | $2.98M | Sell |
109,259
-41,587
| -28% | -$1.13M | 0.83% | 58 |
|
|
2013
Q2 | $4.01M | Buy |
+150,846
| New | +$4.17M | 1.17% | 45 |
|
Other funds holding PFE
Bowling Portfolio Management's PFE Position: Q3 2022 in Review
Bowling Portfolio Management reduced its Pfizer (PFE) stake by 5.3% in Q3 2022, selling an estimated $156K and leaving 57,472 shares worth $2.52M. The position accounts for 0.69% of the portfolio, ranked #36.
Bowling Portfolio Management first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $11.3M in Q3 2016. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Bowling Portfolio Management held 57,472 shares of Pfizer worth $2.52M as of Q3 2022.
- Bowling Portfolio Management sold 3,217 Pfizer shares in Q3 2022, an estimated $156K.
- Pfizer made up 0.69% of Bowling Portfolio Management's portfolio in Q3 2022, its #36 holding.
- Bowling Portfolio Management first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Bowling Portfolio Management's Pfizer position peaked at $11.3M in Q3 2016.
- 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.